PT Organon Pharma Indonesia Tbk engages in manufacturing, packaging, and distributing pharmaceutical products in Indonesia. It provides medicines for diabetes, oncology, hepatitis c, vaccines, and infectious diseases, as well as animal health products. PT Organon Pharma Indonesia Tbk was formerly known as PT Merck Sharp Dohme Pharma Tbk. The company was founded in 1972 and is based in Jakarta, Indonesia. PT Organon Pharma Indonesia Tbk operates as a subsidiary of Organon & Co.
Metrics to compare | SCPI | Peers Peers - average of corresponding metrics from companies closely matching SCPI: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCPIPeersSector |
---|---|---|---|---|
P/E Ratio | Unlock | NaN | NaN | Unlock |
PEG Ratio | Unlock | NaN | NaN | Unlock |
Price/Book | Unlock | NaN | NaN | Unlock |
Price / LTM Sales | Unlock | NaN | NaN | Unlock |
Upside (Analyst Target) | Unlock | NaN | NaN | Unlock |
Fair Value Upside | Unlock | NaN | NaN | Unlock |